carbamates has been researched along with Central Nervous System Origin Vertigo in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We calculated the risk ratio (RR) of ≥50%, ≥75% and 100% reduction in seizure frequency from baseline, as well as dropout and serious adverse events related to treatment." | 2.72 | Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis. ( Wang, C; Wang, J; Zhang, L, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Wang, J | 1 |
| Wang, C | 1 |
| Falutz, SE | 1 |
| McColl, JC | 1 |
| de Oliveira, JM | 1 |
| Chavarría, AP | 1 |
| Swartzwelder, JC | 1 |
| Villarejos, VM | 1 |
| Zeledón, R | 1 |
1 review available for carbamates and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
Topics: Anticonvulsants; Carbamates; Chlorophenols; Dizziness; Dose-Response Relationship, Drug; Drug Resist | 2021 |
3 other studies available for carbamates and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
The laboratory evaluation of anti-vertigo drugs.
Topics: Animals; Carbamates; Cats; Dimenhydrinate; Female; Male; Meprobamate; Nystagmus, Pathologic; Vertigo | 1967 |
[Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
Topics: Aged; Carbamates; Depression; Female; Humans; Intracranial Arteriosclerosis; Male; Mental Fatigue; M | 1970 |
Mebendazole, an effective broad-spectrum anthelmintic.
Topics: Adolescent; Adult; Anthelmintics; Ascariasis; Benzimidazoles; Benzoates; Carbamates; Child; Child, P | 1973 |